Developer docs
API playgroundTry for free, no card

Search company profiles

RoundTable Healthcare Partners

Full company profile

uuid0002ea4

Namestring
RoundTable Healthcare Partners
Legal namestring
RoundTable Healthcare Partners
Company typeenum
Private
Founded yearint
2001
Descriptiontext

RoundTable Healthcare Partners is an operating-oriented private equity firm founded in 2001 and headquartered in Lake Forest, Illinois, focused exclusively on the healthcare industry. The firm has raised $4.25 billion in committed capital across six equity funds totaling $3.65 billion and three subordinated debt funds totaling $600 million, with Fund VI closing at $800 million. RoundTable targets established, profitable healthcare companies with revenues between $25 million and $300 million, making controlling equity investments of approximately $5 to $50 million. The firm generates revenue through annual management fees on committed capital under management and through carried interest on successful portfolio exits.

The firm operates across five core healthcare segments: medical products (devices and disposables), medication delivery systems, specialty pharmaceuticals, specialty distribution, and complementary outsourced services. Notable portfolio companies have spanned consumer healthcare (Colorescience in premium skincare and sun protection, Designs for Health in nutritional supplements), pharmaceutical services (Renaissance Lakewood as a CDMO specializing in nasal and injectable products), specialty pharma (CorePharma, Bioniche, Sabex), and medical devices (Argon Medical Devices, American Medical Instruments Holdings, Excelsior Medical). The firm's go-to-market motion is enterprise field sales through direct industry relationships, and it sells portfolio outputs via multiple channels including professional, direct-to-consumer, e-commerce, and healthcare-practitioner channels.

RoundTable differentiates through deep operating expertise rather than financial engineering, with founding partners and senior team drawing on decades of senior leadership experience at Cardinal Health, Allegiance Corporation, Baxter International, and Credit Suisse First Boston's healthcare investment banking group. The firm provides strategic direction, operational improvements, capital structure optimization, and acquisition execution support to portfolio companies, with a track record including the $565 million sale of Sabex to Sandoz (2004) and the $785 million sale of American Medical Instruments Holdings to Angiotech (2006), which delivered returns in excess of seven times invested equity capital. The firm partners with owner-founders, family companies, management teams, entrepreneurs, and corporate partners seeking both capital and operating resources.

Short descriptiontext

RoundTable Healthcare Partners is an operating-oriented private equity firm founded in 2001, exclusively focused on the healthcare industry. With $4.25 billion in committed capital across six equity funds and three debt funds, the firm partners with management teams of healthcare companies generating $25–300 million in revenue.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLake Forest, United States
HQ citystring
Lake Forest
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, medical products investing, specialty pharmaceuticals investing, healthcare buyout funds, medication delivery systems
NAICS code1 code
  • Management Consulting Services54161
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Private Equity
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management
TypeSubscription Recurring
Description

RoundTable generates revenue through managing private equity funds. The firm has raised $4.25 billion in committed capital across six equity funds totaling $3.65 billion and three subordinated debt funds totaling $600 million.

roundtablehp.com
2Carried Interest / Portfolio Returns
TypeTransaction Fee
Description

The firm earns carried interest from successful portfolio company exits and realizations. Notable exits include Sabex sold to Sandoz for $565 million and American Medical Instruments Holdings sold to Angiotech for $785 million.

roundtablehp.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Fund management fees (not publicly disclosed)
ModelSubscriptionBilling cadenceAnnual
Notes

Private equity fund management fees are typically based on committed capital under management. Specific fee structures are not publicly disclosed.

roundtablehp.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

RoundTable Healthcare Partners is an operating-oriented private equity firm that raises and manages healthcare-focused equity and subordinated debt funds, making controlling equity investments of approximately $5 to $50 million in established, profitable healthcare companies with $25 to $300 million in revenue. The firm partners with owner-founders, family companies, management teams, and corporate partners across medical products, medication delivery systems, specialty pharmaceuticals, specialty distribution, and complementary outsourced services, providing strategic direction, operational expertise, industry relationships, and transaction execution support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Return in excess of 7x invested equity capital from AMIH sale to Angiotech for $785 million
+1 more record
Product overview1 text field

RoundTable Healthcare Partners is an operating-oriented private equity firm focused exclusively on the healthcare industry. The firm creates value by partnering with healthcare companies through six equity funds (totaling $3.65 billion) and three subordinated debt funds (totaling $600 million), collectively raising $4.25 billion in committed capital. The firm's portfolio includes consumer healthcare brands such as Designs for Health (nutritional supplements) and Colorescience (premium skincare and sun protection), as well as CDMO companies like Renaissance Lakewood (nasal and injectable pharmaceuticals). RoundTable focuses on established, profitable healthcare companies in medical products, medication delivery systems, specialty pharmaceuticals, specialty distribution, and complementary outsourced services.

Product and service3 records
1RoundTable Equity Fund VI
CategoryInvestment Fund
2RoundTable Subordinated Debt Funds (Capital Fund series)
CategoryInvestment Fund
3RoundTable Equity Funds I through V
CategoryInvestment Fund
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-02
Description

RoundTable Healthcare Partners acquired Colorescience, a premium skincare and sun protection brand, from shareholders led by 1315 Capital. The transaction represents RoundTable's third platform investment from its $800 million Equity Fund VI and its ninth consumer healthcare platform investment. The partnership aims to support Colorescience's next phase of innovation and growth by leveraging RoundTable's operating resources and channel expertise.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-02-02
Description

Raymond James acted as financial advisor to Colorescience in the transaction.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-02-02
Description

Greenberg Traurig, LLP served as legal counsel to Colorescience in the transaction.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-22
Description

RoundTable Healthcare Partners completed the sale of its minority stake in Designs for Health back to the company. In conjunction with this transaction, DFH announced a new minority investment from BDT & MSD Partners. RoundTable had acquired an interest in Designs for Health in September 2020 and supported key investments in leadership team, operations, and commercial initiatives.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-10-22
Description

Sidley Austin LLP served as legal counsel to RoundTable in the sale of its stake in Designs for Health.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-10-22
Description

Lowenstein Sandler LLP served as legal counsel to Designs for Health in the transaction.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-10-22
Description

Davis Polk & Wardwell LLP served as legal counsel to BDT & MSD Partners in the Designs for Health transaction.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-10-22
Description

Wellvest Capital, LLC served as financial advisor to the Lizotte family and to Designs for Health.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-10-22
Description

Perella Weinberg Partners LP served as financial advisor to Designs for Health.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-10-22
Description

Canaccord Genuity LLC served as financial advisor to Designs for Health.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-13
Description

RoundTable Healthcare Partners portfolio company Renaissance Lakewood entered into a definitive agreement to be acquired by LTS LOHMANN Therapie-Systeme AG. Renaissance was founded by RoundTable through the acquisition of two leading CDMOs, Confab Laboratories in 2010 and DPT Laboratories in 2012. The transaction was expected to close in November 2025.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-13
Description

LTS LOHMANN Therapie-Systeme AG, a pharmaceutical technology company based in Andernach, Germany, acquired Renaissance Lakewood from RoundTable's portfolio. LTS develops and manufactures innovative drug delivery systems.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-10-13
Description

Sidley Austin LLP acted as exclusive legal advisor to Renaissance and RoundTable in the sale transaction to LTS.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused middle-market PE firm headquartered in New York that invests in pharma, medical devices, and healthcare services—directly comparable to RoundTable's sub-sector focus and check size.

TypeDirect peer
Description

Chicago-based healthcare-dedicated PE firm investing in middle-market healthcare companies across services, products, and distribution—comparable operating-oriented model and mid-market healthcare mandate.

TypeDirect peer
Description

Middle-market PE firm with active healthcare practice across medical devices, pharma services, and distribution—comparable target company profile and equity check range to RoundTable.

TypeDirect peer
Description

Specialty industrials and healthcare PE firm investing in lower middle-market companies—including medical products and healthcare services—comparable check size and operating model.

TypeBroad incumbent
Description

TPG's healthcare-focused strategy spanning provider services, pharma, and devices—same vertical focus as RoundTable with broader platform and global reach.

TypeBroad incumbent
Description

Dedicated healthcare investing arm of Bain Capital covering services, biopharma, and devices at scale—same healthcare thesis as RoundTable but at materially larger deal sizes.

TypeDirect peer
Description

Chicago-based PE firm with deep healthcare franchise and Leaders Strategy approach to building platforms through CEO partnerships—comparable operating-oriented mid-market healthcare investing model.

TypeBroad incumbent
Description

Mega-fund with dedicated healthcare franchise covering services, pharma, and devices—overlaps with RoundTable's thesis at the upper end of deal sizes.

TypeDirect peer
Description

Boston-based PE firm focused exclusively on healthcare and life sciences, investing in pharma services, diagnostics, and medical devices—directly overlapping with RoundTable's sub-sector coverage.

TypeBroad incumbent
Description

Established healthcare-focused PE firm with one of the largest dedicated healthcare practices—same sector focus as RoundTable but materially larger AUM and broader fund sizes.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries12 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RoundTable Healthcare Partners

Healthcare Private Equityroundtablehp.com

RoundTable Healthcare Partners is an operating-oriented private equity firm founded in 2001, exclusively focused on the healthcare industry. With $4.25 billion in committed capital across six equity funds and three debt funds, the firm partners with management teams of healthcare companies generating $25–300 million in revenue.

What RoundTable Healthcare Partners does

RoundTable Healthcare Partners is an operating-oriented private equity firm founded in 2001 and headquartered in Lake Forest, Illinois, focused exclusively on the healthcare industry. The firm has raised $4.25 billion in committed capital across six equity funds totaling $3.65 billion and three subordinated debt funds totaling $600 million, with Fund VI closing at $800 million. RoundTable targets established, profitable healthcare companies with revenues between $25 million and $300 million, making controlling equity investments of approximately $5 to $50 million. The firm generates revenue through annual management fees on committed capital under management and through carried interest on successful portfolio exits.

The firm operates across five core healthcare segments: medical products (devices and disposables), medication delivery systems, specialty pharmaceuticals, specialty distribution, and complementary outsourced services. Notable portfolio companies have spanned consumer healthcare (Colorescience in premium skincare and sun protection, Designs for Health in nutritional supplements), pharmaceutical services (Renaissance Lakewood as a CDMO specializing in nasal and injectable products), specialty pharma (CorePharma, Bioniche, Sabex), and medical devices (Argon Medical Devices, American Medical Instruments Holdings, Excelsior Medical). The firm's go-to-market motion is enterprise field sales through direct industry relationships, and it sells portfolio outputs via multiple channels including professional, direct-to-consumer, e-commerce, and healthcare-practitioner channels.

RoundTable differentiates through deep operating expertise rather than financial engineering, with founding partners and senior team drawing on decades of senior leadership experience at Cardinal Health, Allegiance Corporation, Baxter International, and Credit Suisse First Boston's healthcare investment banking group. The firm provides strategic direction, operational improvements, capital structure optimization, and acquisition execution support to portfolio companies, with a track record including the $565 million sale of Sabex to Sandoz (2004) and the $785 million sale of American Medical Instruments Holdings to Angiotech (2006), which delivered returns in excess of seven times invested equity capital. The firm partners with owner-founders, family companies, management teams, entrepreneurs, and corporate partners seeking both capital and operating resources.

RoundTable Healthcare Partners firmographics

Firmographics
Name
RoundTable Healthcare Partners
Legal name
RoundTable Healthcare Partners
Website
https://roundtablehp.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
RoundTable Healthcare Partners is an operating-oriented private equity firm founded in 2001, exclusively focused on the healthcare industry. With $4.25 billion in committed capital across six equity funds and three debt funds, the firm partners with management teams of healthcare companies generating $25–300 million in revenue.
Ownership category
akta.pro rank

Where RoundTable Healthcare Partners is headquartered

Location

Headquarters

HQ city
Lake Forest
HQ country
United States
HQ region
North America

Offices1 record

Markets served

RoundTable Healthcare Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Fund Management: RoundTable generates revenue through managing private equity funds. The firm has raised $4.25 billion in committed capital across six equity funds totaling $3.65 billion and three subordinated debt funds totaling $600 million.
  2. Carried Interest / Portfolio Returns: The firm earns carried interest from successful portfolio company exits and realizations. Notable exits include Sabex sold to Sandoz for $565 million and American Medical Instruments Holdings sold to Angiotech for $785 million.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualFund management fees (not publicly disclosed)

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

RoundTable Healthcare Partners product offering

Product offering

Core offering

RoundTable Healthcare Partners is an operating-oriented private equity firm that raises and manages healthcare-focused equity and subordinated debt funds, making controlling equity investments of approximately $5 to $50 million in established, profitable healthcare companies with $25 to $300 million in revenue. The firm partners with owner-founders, family companies, management teams, and corporate partners across medical products, medication delivery systems, specialty pharmaceuticals, specialty distribution, and complementary outsourced services, providing strategic direction, operational expertise, industry relationships, and transaction execution support.

Product overview

RoundTable Healthcare Partners is an operating-oriented private equity firm focused exclusively on the healthcare industry. The firm creates value by partnering with healthcare companies through six equity funds (totaling $3.65 billion) and three subordinated debt funds (totaling $600 million), collectively raising $4.25 billion in committed capital. The firm's portfolio includes consumer healthcare brands such as Designs for Health (nutritional supplements) and Colorescience (premium skincare and sun protection), as well as CDMO companies like Renaissance Lakewood (nasal and injectable pharmaceuticals). RoundTable focuses on established, profitable healthcare companies in medical products, medication delivery systems, specialty pharmaceuticals, specialty distribution, and complementary outsourced services.

Differentiator

Problem solved

Functional benefit

Products and services

  • RoundTable Equity Fund VI
  • RoundTable Subordinated Debt Funds (Capital Fund series)
  • RoundTable Equity Funds I through V

Quantifiable outcome

  • Return in excess of 7x invested equity capital from AMIH sale to Angiotech for $785 million
  • +1 more outcomes

Companies that use RoundTable Healthcare Partners

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles2 records

RoundTable Healthcare Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

RoundTable Healthcare Partners partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • ColoresciencecoreStrategic or Co-development Partner · 2 February 2026RoundTable Healthcare Partners acquired Colorescience, a premium skincare and sun protection brand, from shareholders led by 1315 Capital. The transaction represents RoundTable's third platform investment from its $800 million Equity Fund VI and its ninth consumer healthcare platform investment. The partnership aims to support Colorescience's next phase of innovation and growth by leveraging RoundTable's operating resources and channel expertise.
  • Raymond JamesminorImplementation/ SI/ Consulting Partner · 2 February 2026Raymond James acted as financial advisor to Colorescience in the transaction.
  • Greenberg Traurig, LLPminorImplementation/ SI/ Consulting Partner · 2 February 2026Greenberg Traurig, LLP served as legal counsel to Colorescience in the transaction.
  • Designs for HealthcoreStrategic or Co-development Partner · 22 October 2025RoundTable Healthcare Partners completed the sale of its minority stake in Designs for Health back to the company. In conjunction with this transaction, DFH announced a new minority investment from BDT & MSD Partners. RoundTable had acquired an interest in Designs for Health in September 2020 and supported key investments in leadership team, operations, and commercial initiatives.
  • Sidley Austin LLPminorImplementation/ SI/ Consulting Partner · 22 October 2025Sidley Austin LLP served as legal counsel to RoundTable in the sale of its stake in Designs for Health.
  • Lowenstein Sandler LLPminorImplementation/ SI/ Consulting Partner · 22 October 2025Lowenstein Sandler LLP served as legal counsel to Designs for Health in the transaction.
  • Davis Polk & Wardwell LLPminorImplementation/ SI/ Consulting Partner · 22 October 2025Davis Polk & Wardwell LLP served as legal counsel to BDT & MSD Partners in the Designs for Health transaction.
  • Wellvest Capital, LLCminorImplementation/ SI/ Consulting Partner · 22 October 2025Wellvest Capital, LLC served as financial advisor to the Lizotte family and to Designs for Health.
  • Perella Weinberg Partners LPminorImplementation/ SI/ Consulting Partner · 22 October 2025Perella Weinberg Partners LP served as financial advisor to Designs for Health.
  • Canaccord Genuity LLCminorImplementation/ SI/ Consulting Partner · 22 October 2025Canaccord Genuity LLC served as financial advisor to Designs for Health.
  • Renaissance LakewoodcoreStrategic or Co-development Partner · 13 October 2025RoundTable Healthcare Partners portfolio company Renaissance Lakewood entered into a definitive agreement to be acquired by LTS LOHMANN Therapie-Systeme AG. Renaissance was founded by RoundTable through the acquisition of two leading CDMOs, Confab Laboratories in 2010 and DPT Laboratories in 2012. The transaction was expected to close in November 2025.
  • LTS LOHMANN Therapie-Systeme AGminorStrategic or Co-development Partner · 13 October 2025LTS LOHMANN Therapie-Systeme AG, a pharmaceutical technology company based in Andernach, Germany, acquired Renaissance Lakewood from RoundTable's portfolio. LTS develops and manufactures innovative drug delivery systems.
  • Sidley Austin LLPminorImplementation/ SI/ Consulting Partner · 13 October 2025Sidley Austin LLP acted as exclusive legal advisor to Renaissance and RoundTable in the sale transaction to LTS.

Scale indicators7 records

Recent moves11 records

Expansion highlights5 records

RoundTable Healthcare Partners competitors and assessment

Company assessment

Direct peers

  • Avista Capital Partners: Healthcare-focused middle-market PE firm headquartered in New York that invests in pharma, medical devices, and healthcare services—directly comparable to RoundTable's sub-sector focus and check size.
  • Linden Capital Partners: Chicago-based healthcare-dedicated PE firm investing in middle-market healthcare companies across services, products, and distribution—comparable operating-oriented model and mid-market healthcare mandate.
  • Audax Group: Middle-market PE firm with active healthcare practice across medical devices, pharma services, and distribution—comparable target company profile and equity check range to RoundTable.
  • Arsenal Capital Partners: Specialty industrials and healthcare PE firm investing in lower middle-market companies—including medical products and healthcare services—comparable check size and operating model.
  • GTCR: Chicago-based PE firm with deep healthcare franchise and Leaders Strategy approach to building platforms through CEO partnerships—comparable operating-oriented mid-market healthcare investing model.
  • Ampersand Capital Partners: Boston-based PE firm focused exclusively on healthcare and life sciences, investing in pharma services, diagnostics, and medical devices—directly overlapping with RoundTable's sub-sector coverage.

Broad incumbents

  • TPG Capital Healthcare: TPG's healthcare-focused strategy spanning provider services, pharma, and devices—same vertical focus as RoundTable with broader platform and global reach.
  • Bain Capital Healthcare: Dedicated healthcare investing arm of Bain Capital covering services, biopharma, and devices at scale—same healthcare thesis as RoundTable but at materially larger deal sizes.
  • Apollo Global Management Healthcare: Mega-fund with dedicated healthcare franchise covering services, pharma, and devices—overlaps with RoundTable's thesis at the upper end of deal sizes.
  • Welsh, Carson, Anderson & Stowe: Established healthcare-focused PE firm with one of the largest dedicated healthcare practices—same sector focus as RoundTable but materially larger AUM and broader fund sizes.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

RoundTable Healthcare Partners social profiles

Digital presence

RoundTable Healthcare Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RoundTable Healthcare Partners leadership team

Management profile

Number of profiles

Profiles11 records

RoundTable Healthcare Partners subsidiaries and ownership

Company hierarchy

Subsidiaries12 records

RoundTable Healthcare Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RoundTable Healthcare Partners M&A and investment

M&A and investment

M&A7 records

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RoundTable Healthcare Partners

What does RoundTable Healthcare Partners do?

RoundTable Healthcare Partners is an operating-oriented private equity firm that raises and manages healthcare-focused equity and subordinated debt funds, making controlling equity investments of approximately $5 to $50 million in established, profitable healthcare companies with $25 to $300 million in revenue. The firm partners with owner-founders, family companies, management teams, and corporate partners across medical products, medication delivery systems, specialty pharmaceuticals, specialty distribution, and complementary outsourced services, providing strategic direction, operational expertise, industry relationships, and transaction execution support.

Is RoundTable Healthcare Partners a public or private company?

RoundTable Healthcare Partners is a private company. It is classified as private equity controlled and is currently operating.

When was RoundTable Healthcare Partners founded?

RoundTable Healthcare Partners was founded in 2001. It employs 11 to 50 people.

Where is RoundTable Healthcare Partners based?

RoundTable Healthcare Partners is headquartered in Lake Forest, United States, in the North America region.

How does RoundTable Healthcare Partners make money?

Two revenue lines are on record. Fund Management is the primary driver. The others are carried Interest / Portfolio Returns.

Who are RoundTable Healthcare Partners's main competitors?

Direct peers on record are Avista Capital Partners, Linden Capital Partners, Audax Group, Arsenal Capital Partners, GTCR and Ampersand Capital Partners. Broad incumbents are TPG Capital Healthcare, Bain Capital Healthcare, Apollo Global Management Healthcare and Welsh, Carson, Anderson & Stowe.

Does RoundTable Healthcare Partners have an API?

No public API is recorded for RoundTable Healthcare Partners.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AdvfnRoundTable Healthcare Partners Appoints Ed Jones as Operating PartnerRoundTable Healthcare Partners appointed Ed Jones as Operating Partner, bringing nearly 14 years as CEO of HealthTrust Performance Group. The hire is the second operating partner this year, following Amardeep Kahlon's appointment in May, reflecting the firm's commitment to building operating expertise for its portfolio companies.PR NewswireRoundTable Healthcare Partners Appoints Ed Jones as Operating PartnerRoundTable Healthcare Partners appointed Ed Jones as Operating Partner, bringing nearly 14 years as CEO of HealthTrust Performance Group. The hire is the second operating partner this year, following Amardeep Kahlon's appointment in May. Jones will work with investment and operating teams to accelerate value creation at portfolio companies.PrivateequitywireRoundTable Healthcare Partners adds operating partner to strengthen value-creationRoundTable Healthcare Partners appointed Amardeep Kahlon as operating partner, who previously led Designs for Health, a fund exited in October 2025. He will support portfolio performance and new investment evaluation, focusing on consumer healthcare assets. The firm has raised about $4.25bn across funds and credit vehicles.PR NewswireRoundTable Healthcare Partners Appoints Amardeep Kahlon as Operating PartnerRoundTable Healthcare Partners, an operating-oriented private equity firm focused on the healthcare industry, has appointed Amardeep Kahlon as Operating Partner. Kahlon brings extensive consumer healthcare experience, most recently serving as CEO of Designs for Health, a RoundTable Fund V portfolio company that successfully exited in October 2025, and previously holding senior roles at Reckitt US Nutrition and GSK US Consumer Healthcare. In his new role, Kahlon will work with RoundTable's investment and operating teams to accelerate value creation at portfolio companies and evaluate new investment opportunities.Venture Capital Access OnlineRoundTable Healthcare Partners Appoints Amardeep Kahlon as Operating PartnerRoundTable Healthcare Partners appointed Amardeep Kahlon as Operating Partner, effective immediately. Kahlon previously served as CEO of Designs for Health, a RoundTable Fund V investment, and held senior roles at Reckitt and GSK. He will work with investment and operating teams to accelerate value creation at portfolio companies.Pulse 2.0Colorescience Raises Funding From RoundTable Healthcare PartnersRoundTable Healthcare Partners invested in Colorescience, a mineral-based skincare and sun protection brand, with terms undisclosed. The deal was financed with senior debt led by Capital One, and RoundTable said it is its ninth consumer healthcare investment. Colorescience plans to expand brand awareness and product portfolio.PR NewswireROUNDTABLE HEALTHCARE PARTNERS INVESTS IN COLORESCIENCE, A PREMIUM SKINCARE AND SUN PROTECTION BRANDRoundTable Healthcare Partners, a private equity firm focused on the healthcare industry, announced a partnership and investment in Colorescience, Inc., a premium skincare and sun protection brand headquartered in Carlsbad, California. The transaction involves RoundTable acquiring the company from shareholders led by 1315 Capital, representing RoundTable's ninth consumer healthcare platform investment and third platform investment from its $800 million Equity Fund VI. The companies expect the partnership to accelerate Colorescience's brand expansion and product portfolio growth while leveraging RoundTable's operating resources and channel expertise.Venture Capital Access OnlineROUNDTABLE HEALTHCARE PARTNERS INVESTS IN COLORESCIENCE, A PREMIUM SKINCARE AND SUN PROTECTION BRANDRoundTable Healthcare Partners announced a partnership and investment in Colorescience, Inc., acquiring the premium skincare and sun protection brand from shareholders led by 1315 Capital; terms were not disclosed. The transaction represents RoundTable's third platform investment from its $800 million Equity Fund VI and ninth consumer healthcare platform investment overall. Colorescience, known for its mineral-based, clinically validated products, serves customers through an omni-channel model spanning professional, direct-to-consumer, and e-commerce channels, and is well positioned to expand brand awareness and product portfolio with RoundTable's operational support.BusinessoffashionColorescience Is Acquired by Roundtable Healthcare PartnersColorescience, a skincare brand specializing in powder sunscreen and SPF-infused makeup, was acquired by private equity firm Roundtable Healthcare Partners on February 2. The acquisition, from a 1315 Capital-led group of shareholders that had invested $15 million in the company via a Series C round in 2017, marks Roundtable's ninth consumer healthcare investment. The PE firm cited Colorescience's distribution network at medical spas and dermatologist clinics as a key draw, with plans to pursue expansion through increased brand awareness, greater channel penetration, and new product launches.GloballegalchronicleRoundTable Healthcare Partners Sells Minority Stake in Designs for Health Amid New Investment – Global Legal ChronicleRoundTable Healthcare Partners has sold a minority stake in Designs for Health to BDT & MSD as part of a new investment in the company. The transaction involved legal advisors Sidley Austin for RoundTable, Lowenstein Sandler for Designs for Health, and Davis Polk for BDT & MSD. Details of the stake size and financial terms of the investment were not disclosed.